MXRA5 and acute myeloid leukemia: MXRA5 exhibits anti-inflammatory and anti-fibrotic properties and has been implicated in tumorigenesis, serving as a potential biomarker for multiple malignancies, including colorectal, lung, pancreatic, and gastric cancers, as well as glioma and acute myeloid leukemia [25,26,27,28].